DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Ducore J, Alexander WA, Mitchell IS, Lawrence J, Grandoni J, Bonzo D.
Potential clinical trial validation of differential EPCR-dependent activity by eptacog beta, a rhFVIIa, in the treatment of bleeding in hemophilia patients with inhibitors.
Research and Practice in Thrombosis and Haemostasis 2018;
2 (S1) PB197
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.